Federal Circuit denies Illumina’s writ request in Ariosa dispute

10-03-2017

The US Court of Appeals for the Federal Circuit has said it won’t review a writ filed by Illumina and its subsidiary Verinata Health in a patent dispute with Ariosa Diagnostics.


Federal circuit, petition, IPR, patent, Illumina, Verinata, Ariosa, Roche

LSIPR